Pulmonology
SHM Converge
Evidence or anecdote: Clinical judgment in COVID care
Friendly debate emphasizes the need to weigh evidence for drug treatment of COVID-19.
News
Weight-related COVID-19 severity starts in normal BMI range, especially in young
Clinical
Ruling out PE in patients with low C-PTP and D dimer of less than 1,000 ng/mL
Can we rule out pulmonary embolism (PE) in patients with a low clinical pretest probability (C-PTP) and a D dimer of less than 1,000 ng/mL?
News
Pediatric bronchiolitis: Less is more
With bronchiolitis still the poster disease for low-value interventions, it’s time to retire widely used but ineffective therapies and focus on...
News
Pneumonia risk soars in heart failure patients, especially HFpEF
An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular...
News
How some COVID-19 vaccines could cause rare blood clots
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
News
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
Clinical
New guidelines on the diagnosis and treatment of adults with CAP
What are the most up-to-date, evidence-based recommendations for the diagnosis and treatment of community-acquired pneumonia (CAP)?
Clinical
Metoprolol increases severity, but not risk, of COPD exacerbations
Does metoprolol affect time until exacerbation in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without an...
Clinical
The revenge of the ‘late COVID adopters’
COVID-19–related ARDS and VTE data reinforce how difficult it is to obtain high-quality data that yield clear results.